Content area
Full text
Keystone Nano, a clinical stage biopharmaceutical company focused on improving cancer treatments through the application of nanotechnology, announced significant progress on the delivery of RNA using NanoJackets (NJs). KN's NanoJackets are proprietary, customizable calcium phosphate nanoparticles that protect the active agent in the bloodstream and deliver it to targeted cells. Key recent achievements include:
* substantial new knowledge on encapsulating various kinds of RNA including siRNA, micro RNA and messenger RNA,
* improved knowledge about the safety/toxicity of the NanoJacketed RNA,
* new understanding...